Obesity-drug maker Metsera Inc.'s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts Friday ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...
Medability GmbH, a German medical technology company, will establish its U.S. headquarters in Tampa. It's the latest foreign ...
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
The Food and Drug Administration has updated the recall of Broccoli florets sold at Walmart to class I risk level, which is ...
ColdVentures enters exclusive distribution partnership with Medco Sports Medicine: Los Angeles Monday, January 27, 2025, 16:00 Hrs [IST] ColdVentures, a leading medical device com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback